IVAN ANDRES MORALES

Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology HUNTSVILLE, AL NPI 1689167264

General Payments — all program years on this page

$3,275.35

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 27
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $2,833.99 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Travel and Lodging $1,484.814
Food and Beverage $1,349.1816

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Penumbra, Inc. $2,053.438
Inari Medical, Inc. $743.5110
Acerta Pharma LLC $21.321
Galvanize Therapeutics, Inc $15.731

By program year

Program yearAmountRecords
2019 $180.752
2023 $260.615
2024 $2,833.9920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1076218796 Penumbra, Inc. $33.48 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1076218798 Penumbra, Inc. $39.32 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1076218800 Penumbra, Inc. $185.54 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1076230552 Penumbra, Inc. $310.28 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1076231168 Penumbra, Inc. $527.80 04/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1076231744 Penumbra, Inc. $49.55 04/28/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1076232230 Penumbra, Inc. $851.19 04/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1076232886 Penumbra, Inc. $56.27 04/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1104250669 AstraZeneca Pharmaceuticals LP $21.32 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140145457 Inari Medical, Inc. $183.08 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140145461 Inari Medical, Inc. $31.29 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140145464 Inari Medical, Inc. $36.17 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140145468 Inari Medical, Inc. $34.42 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140145471 Inari Medical, Inc. $28.42 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140145475 Inari Medical, Inc. $25.90 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140145479 Inari Medical, Inc. $16.62 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140145483 Inari Medical, Inc. $92.18 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140145487 Inari Medical, Inc. $170.90 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140145491 Inari Medical, Inc. $124.53 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144504624 Galvanize Therapeutics, Inc $15.73 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.